Acrivon Therapeutics, Inc. Quarterly Assets in USD from Q4 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Acrivon Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2021 to Q3 2024.
Acrivon Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $215M, a 42.1% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$215M	+$63.6M	+42.1%	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	$231M	+$70.5M	+44.1%	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$121M	-$49.7M	-29.2%	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$138M	-$43M	-23.7%	Dec 31, 2023	10-Q	2024-11-13
Q3 2023	$151M	+$63.4M	+72.3%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$160M			Jun 30, 2023	10-Q	2023-08-11
Q1 2023	$170M			Mar 31, 2023	10-Q	2023-05-09
Q4 2022	$181M	+$74.6M	+70%	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$87.7M			Sep 30, 2022	10-Q	2022-12-15
Q4 2021	$107M			Dec 31, 2021	10-K	2023-03-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.